HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Marti, L. Articles by Zorzano, A. Search for Related Content PubMed PubMed Citation Articles by Marti, L. Articles by Zorzano, A. Social Bookmarking                What's this?

Combined Treatment With Benzylamine and Low Dosages of Vanadate Enhances Glucose Tolerance and Reduces Hyperglycemia in Streptozotocin-Induced Diabetic Rats

¹ Departament de Bioquìmica i Biologia Molecular, Facultat de Biologia, Universitat de Barcelona, Barcelona, Spain
² Institut National de la Santé et de la Recherche Médicale (INSERM U 317), Toulouse, France

Semicarbazide-sensitive amine oxidase (SSAO) is highly expressed in adipose cells, and substrates of SSAO, such as benzylamine, in combination with low concentrations of vanadate strongly stimulate glucose transport and GLUT4 recruitment in 3T3-L1 and rat adipocytes. Here we examined whether acute and chronic administration of benzylamine and vanadate in vivo enhances glucose tolerance and reduces hyperglycemia in diabetic rats. Acute intravenous administration of these drugs enhanced glucose tolerance in nondiabetic rats and in streptozotocin (STZ)-induced diabetic rats. This occurred in the absence of changes in plasma insulin concentrations. However, the administration of benzylamine or vanadate alone did not improve glucose tolerance. The improvement caused by benzylamine plus vanadate was abolished when rats were pretreated with the SSAO-inhibitor semicarbazide. Chronic administration of benzylamine and vanadate exerted potent antidiabetic effects in STZ-induced diabetic rats. Although daily administration of vanadate alone (50 and 25 µmol · kg^-1 · day^-1 i.p.) for 2 weeks had little or no effect on glycemia, vanadate plus benzylamine reduced hyperglycemia in diabetic rats, enhanced basal and insulin-stimulated glucose transport, and upregulated GLUT4 expression in isolated adipocytes. In all, our results substantiated that acute and chronic administration of benzylamine with low dosages of vanadate have potent antidiabetic effects in rats.

CiteULike

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

				S. Garcia-Vicente, F. Yraola, L. Marti, E. Gonzalez-Munoz, M. J. Garcia-Barrado, C. Canto, A. Abella, S. Bour, R. Artuch, C. Sierra, et al. Oral Insulin-Mimetic Compounds That Act Independently of Insulin Diabetes, February 1, 2007; 56(2): 486 - 493. [Abstract] [Full Text] [PDF]

				M. C. Iglesias-Osma, M. J. Garcia-Barrado, V. Visentin, M. F. Pastor-Mansilla, S. Bour, D. Prevot, P. Valet, J. Moratinos, and C. Carpene Benzylamine Exhibits Insulin-Like Effects on Glucose Disposal, Glucose Transport, and Fat Cell Lipolysis in Rabbits and Diabetic Mice J. Pharmacol. Exp. Ther., June 1, 2004; 309(3): 1020 - 1028. [Abstract] [Full Text] [PDF]

				P. H. Yu, M. Wang, H. Fan, Y. Deng, and D. Gubisne-Haberle Involvement of SSAO-mediated deamination in adipose glucose transport and weight gain in obese diabetic KKAy mice Am J Physiol Endocrinol Metab, April 1, 2004; 286(4): E634 - E641. [Abstract] [Full Text] [PDF]

				A. Tardif, N. Julien, J.-L. Chiasson, and L. Coderre Stimulation of glucose uptake by chronic vanadate pretreatment in cardiomyocytes requires PI 3-kinase and p38 MAPK activation Am J Physiol Endocrinol Metab, June 1, 2003; 284(6): E1055 - E1064. [Abstract] [Full Text] [PDF]

				A. Abella, L. Marti, M. Camps, M. Claret, J. Fernandez-Alvarez, R. Gomis, A. Guma, N. Viguerie, C. Carpene, M. Palacin, et al. Semicarbazide-Sensitive Amine Oxidase/Vascular Adhesion Protein-1 Activity Exerts an Antidiabetic Action in Goto-Kakizaki Rats Diabetes, April 1, 2003; 52(4): 1004 - 1013. [Abstract] [Full Text] [PDF]

				N. Mercier, M. Moldes, K. E. Hadri, and B. Feve Regulation of Semicarbazide-Sensitive Amine Oxidase Expression by Tumor Necrosis Factor-alpha in Adipocytes: Functional Consequences on Glucose Transport J. Pharmacol. Exp. Ther., March 1, 2003; 304(3): 1197 - 1208. [Abstract] [Full Text] [PDF]

				N. Morin, V. Visentin, D. Calise, L. Marti, A. Zorzano, X. Testar, P. Valet, Y. Fischer, and C. Carpene Tyramine Stimulates Glucose Uptake in Insulin-Sensitive Tissues in Vitro and in Vivo via Its Oxidation by Amine Oxidases J. Pharmacol. Exp. Ther., December 1, 2002; 303(3): 1238 - 1247. [Abstract] [Full Text] [PDF]

				M. Salmi, C. Stolen, P. Jousilahti, G. G. Yegutkin, P. Tapanainen, T. Janatuinen, M. Knip, S. Jalkanen, and V. Salomaa Insulin-Regulated Increase of Soluble Vascular Adhesion Protein-1 in Diabetes Am. J. Pathol., December 1, 2002; 161(6): 2255 - 2262. [Abstract] [Full Text] [PDF]